Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5641009 | Journal of Endodontics | 2017 | 7 Pages |
Abstract
GuttaFlow Bioseal and GuttaFlow2 showed lower cytotoxicity than MTA Fillapex and AH plus. Further in vitro and in vivo investigations are required to confirm the suitability of GuttaFlow Bioseal for clinical application.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Mar BSc, MBB, MSc, Christopher J. DDS, MSc, Ricardo E. MD, DDS, PhD, José M. MD, PhD, Francisco J. DDS, PhD,